Lunai Bioworks (LNAI) Accumulated Expenses (2012 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Accumulated Expenses of $4.9 million in Q1 2026, little changed quarter-over-quarter from $4.9 million in Q4 2025, and down 14.05% on a YoY basis from $5.7 million in Q1 2025.
Lunai Bioworks (LNAI) Accumulated Expenses (2012 - 2026) Analysis & Trends
Lunai Bioworks' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 14.05% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 14.05% YoY), while the FY2025 annual figure was $5.8 million, up 10.01% from the prior year.
- Accumulated Expenses was $4.9 million for Q1 2026 at Lunai Bioworks, roughly flat from $4.9 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $5.8 million in Q2 2025 to a low of $7875.0 in Q3 2023.
- Historically, Accumulated Expenses has averaged $3.0 million across 5 years, with a median of $3.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 99.24% in 2023, then surged 67956.56% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $932603.0 in 2022, then fell by 15.98% to $783601.0 in 2023, then surged by 603.42% to $5.5 million in 2024, then declined by 10.6% to $4.9 million in 2025, then fell by 0.3% to $4.9 million in 2026.
- The last three Accumulated Expenses figures came in at $4.9 million (Q1 2026), $4.9 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 5.84 Mn |
| Mar 31, 2025 | 5.72 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 783,601.00 |
| Sep 30, 2023 | 7,875.00 |
| Jun 30, 2023 | 723,173.00 |
| Mar 31, 2023 | 593,728.00 |
| Dec 31, 2022 | 932,603.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 466,324.00 |
| Dec 31, 2021 | 504,383.00 |
| Sep 30, 2021 | 364,769.00 |
| Jun 30, 2021 | 1.18 Mn |